3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
4
Leiomyoma
4
Ovarian Neoplasms
3
Endometrial Neoplasms
3
Uterine Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Dysplasia
1
Precancerous Conditions
1
Myofibroma
1
Metrorrhagia
1
Menstruation Disturbances
1
Menorrhagia
1
Hysterectomy
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Endometriosis
1
Endometrial Hyperplasia
1
Disease
1
Carcinoma, Squamous Cell
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Endometrioid
1
Carcinoma, Adenosquamous
1
Adenomyosis
1
Adenocarcinoma
1
Interventions
Metformin
3
drospirenone and ethinyl estradiol combination
2
Caloric Restriction
2
cinnulin PF
1
Yoga
1
Sugars
1
Robotic Surgical Procedures
1
Population Groups
1
Hysterectomy
1
Glucose Tolerance Test
1
Folic Acid
1
Ethinyl Estradiol
1
Doxycycline
1
Diet
1
Cyproterone acetate, ethinyl estradiol drug combination
1
Control Groups
1
Contraceptives, Oral
1
Acupuncture Therapy
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Menstruation Disturbances
×
Hysterectomy
×
Clear all
NCT07120945
2026-03-06
Embrace Gyn
Medtronic - MITG
Phase NA
Recruiting
70 enrolled